科学家们让失明的实验鼠恢复了视力,并希望利用这一成果帮助人类
(2016-07-26 10:40:46)
内容来源:分享美国 地址链接:http://go.usa.gov/xrd6x
大多数科学家曾一度认为,哺乳动物的脑细胞一旦受损,将永远无法修复。但加利福尼亚州(California)斯坦福大学(Stanford
University)的研究人员成功地再生了实验鼠受损的视神经,使我们相信类似的治疗方法有希望帮助患有青光眼、老年痴呆症,甚至脊髓损伤的人。
他们是如何做到的呢?有两种方法:打开“生长开关“,一个鼓励细胞在中枢神经系统中生长的基因;以及让实验鼠观看鲜艳的、不断变化的图案,“活动”它的眼睛。
首席研究员安德鲁·休伯曼(Andrew Huberman)说: “当我们将这两种方法结合起来,我们看到了这个令人惊叹的协同效应。神经元的长度大大增加了——比通常情况下更长、更快500倍。”
没有参与这项研究的华盛顿大学(University of Washington)的罗素·范·盖尔德(Russell Van Gelder)表示,这一策略实际上就是在早期大脑中发生的情况。“这表明,在发育期发生在大脑和眼睛之间的对话……可以恢复。”
休伯曼说,不仅神经元或神经细胞出现生长,而且在再生过程中它们似乎确切地知道生长的方向。虽然视力恢复的情况并不完美,但这项研究中一度失明的实验鼠通过了视觉能力基本测试。
这项成果给研究人员带来了希望,像青光眼这种影响全球7000万人的疾病可以被治愈,而且其他类型的大脑和神经细胞也可以以类似的方式再生。这可能意味着恢复被阿尔茨海默氏症破坏的记忆路径,或恢复脊髓受损的患者的运动能力。
After giving blind mice vision, scientists hope to help humans
Most scientists once thought that the brain cells of mammals, once damaged, could never be repaired. But researchers at Stanford University in California have regrown damaged optic nerves in mice, restoring hope that similar treatments could help people with glaucoma, Alzheimer’s disease and even spinal cord injuries.
How did they do it? With two methods: flipping on a “growth switch,” a gene that encourages growth of cells in the central nervous system, and “exercising” the eye by having mice look at displays of bold, shifting patterns.
“When we combined those two,”
This strategy is actually what happens in the early brain, said Russell Van Gelder of the University of Washington, who was not involved with the study. “It suggests that the conversation that occurred between the brain and eye in development … can be revived.”
Not only did the neurons, or nerve cells, grow, but
they
The work gives researchers hope that diseases like glaucoma, which
affects 70 million people around the world, could be reversed, and
that other types of brain and nerve cells can be regrown in similar
ways. This could mean restoring
“Before, there was nothing we could do,” said Zhigang He, a co-author of the paper. “Now, we need to think about what type of patient might be most likely to benefit from the treatment.”